Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.
Metrics to compare | 4166 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4166PeersSector | |
---|---|---|---|---|
P/E Ratio | 62.9x | −14.4x | −0.5x | |
PEG Ratio | 0.63 | 0.10 | 0.00 | |
Price/Book | 4.1x | 2.1x | 2.6x | |
Price / LTM Sales | 6.0x | 5.4x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 42.9% | |
Fair Value Upside | Unlock | −3.0% | 6.2% | Unlock |